We studied the increased levels of hemoglobins AIa+Ib and AIc in five hospitalized diabetic patients to determine whether changes in diabetic control would cause parallel changes in the levels of these hemoglobins. Before control of diabetes the mean fasting blood sugar for all patients was 343 mg per deciliter (range, 280 to 450), and hemoglobin AIc concentration 9.8 per cent (range, 6.8 to 12.1). During optimal diabetic control the blood sugar concentration was 84 mg per deciliter (range, 70 to 100), and hemoglobin AIc concentration 5.8 per cent (range, 4.2 to 7.6). Hemoglobin AIc concentration appears to reflect the mean blood sugar concentration best over previous weeks to months. The periodic monitoring of hemoglobin AIc levels provides a useful way of documenting the degree of control of glucose metabolism in diabetic patients and provides a means whereby the relation of carbohydrate control to the development of sequelae can be assessed.
A series of group 4 metallocenes possessing chiral ligand environments have been characterized and their structures are compared with their propylene polymerizations. Isotactic, syndiotactic, hemiisotactic, and atactic polypropylenes are produced selectively with chiral monoalkyl metallocene cations paired with perfluorotetraphenyl borate; analogous to the results obtained using methylaluminoxane as a cocatalyst. The relative catalyst stereospecificities suggest specific π‐face selectivities and nonbonded contacts. Trends with solvents, temperatures, and catalyst structures are consistent with contact ion pairing for iPr[CpFlu]Zr‐P(+) in liquid propylene. The specificities of differently structured metallocenes imply chain‐migratory monomer addition reactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.